Advertisement
UK markets closed

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     

  • AIM

    745.67
    +0.38 (+0.05%)
     

  • GBP/EUR

    1.1629
    -0.0055 (-0.47%)
     

  • GBP/USD

    1.2383
    -0.0055 (-0.44%)
     

  • Bitcoin GBP

    51,725.96
    +389.77 (+0.76%)
     

  • CMC Crypto 200

    1,371.72
    +59.10 (+4.50%)
     

  • S&P 500

    4,975.58
    -35.54 (-0.71%)
     

  • DOW

    37,892.70
    +117.32 (+0.31%)
     

  • CRUDE OIL

    82.94
    +0.21 (+0.25%)
     

  • GOLD FUTURES

    2,409.80
    +11.80 (+0.49%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

3 Healthcare Stocks That Might Soar if Biden Gets This Part of His Budget Approved

Jason Hawthorne, The Motley Fool
·5-min read
3 Healthcare Stocks That Might Soar if Biden Gets This Part of His Budget Approved

One of the most notable items in Joe Biden's recent budget proposal is $6.5 billion to create an agency called the Advanced Research Projects Agency for Health, or ARPA-H. The naming is intended to mirror DARPA, the defense agency that had a hand in producing the internet, GPS, and Boston Dynamics robots like this. The goal of the agency would be to lead the charge in curing cancer, Alzheimer's, and diabetes. If the agency is created, that could send funding toward cutting-edge diabetes research from companies like CRISPR Therapeutics (NASDAQ: CRSP) and Vertex Pharmaceuticals (NASDAQ: VRTX), as well as those helping better manage the disease like Teladoc's (NYSE: TDOC) Livongo unit.

Continue reading